Omada Health, Inc. (OMDA): EBITDA
-$6.48M
Year ended 2025-12-31
$13.09M
Trailing 12 months to 2026-09-30
| Period ended | EBITDA | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$6.48M | n/m | 2026-03-06, From 2025-01-01 |
| 2024-12-31 | -$38.85M | n/m | 2026-03-06, From 2024-01-01 |
| 2023-12-31 | -$61.55M | n/a | 2026-03-06, From 2023-01-01 |
EBITDA at similar companies
| Company | Year ended | EBITDA | Change YoY |
|---|---|---|---|
| Omada Health, Inc. (OMDA) | 2025-12-31 | -$6.48M | n/m |
| GeneDx Holdings Corp. (WGS) | 2025-12-31 | -$3.48M | n/m |
| U S Physical Therapy Inc (USPH) | 2025-12-31 | $109.07M | +33.5% |
| Pennant Group, Inc. (PNTG) | 2025-12-31 | $60.42M | +36.6% |
| InnovAge Holding Corp. (INNV) | 2026-06-30 | $23.76M | n/m |
| LifeStance Health Group, Inc. (LFST) | 2025-12-31 | $65.77M | +625.6% |
| P3 Health Partners Inc. (PIII) | 2025-12-31 | -$186.14M | n/m |
| Privia Health Group, Inc. (PRVA) | 2025-12-31 | $44.14M | +82.0% |
| Vsee Health, Inc. (VSEE) | 2025-12-31 | -$7.00M | n/m |
Compare OMDA, WGS, USPH, PNTG side by side · Screen every company in Services-Health Services ↗